Project/Area Number |
16K20166
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Urology
|
Research Institution | Aichi Medical University |
Principal Investigator |
|
Project Period (FY) |
2016-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2017: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 前立腺癌 / 前立腺針生検 / 生検腫瘍量 / 生検コア腫瘍量 / Insignificant cancer / active surveillance / 腫瘍体積 / 合計コア腫瘍長 / insignificant cancer / 前立腺病理 / 腫瘍学 |
Outline of Final Research Achievements |
There is recent concern that widespread PSA testing and extended‐core needle biopsies have led to the overtreatment of PCa, particularly when detected at its early stages. We developed a novel biopsy instrument that extends the side-notch length to 25 mm and the stroke length to 28 mm, and here we report the results of our evaluation of its impact on the detection of prostate cancer in TRNB. The novel biopsy instrument with a 25 mm side-notch can take longer tissue samples safely and has a higher rate of prostate cancer detection in transrectal biopsy. Our data suggest that total length of cancer in cores is the optimal measure of tumor extent in prostate biopsy specimens for identifying small‐volume prostate cancer.
|